| Trial ID: | L4685 |
| Source ID: | NCT00654121
|
| Associated Drug: |
Actrapid Hm
|
| Title: |
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes, Type I
|
| Interventions: |
DRUG: Actrapid HM
|
| Outcome Measures: |
Primary: Fasting glycemia;, 2004|fasting and stimulated plasma C-peptide and proinsulin values;, 2004|islet cell autoantibodies;, 2004|body weight gain., 2004 |
|
| Sponsor/Collaborators: |
Sponsor: AZ-VUB | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
112
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2000-02
|
| Completion Date: |
2007-11
|
| Results First Posted: |
|
| Last Update Posted: |
2008-04-07
|
| Locations: |
Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium|Academisch Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB, Brussels, 1090, Belgium|Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL, Leuven, 3000, Belgium
|
| URL: |
https://clinicaltrials.gov/show/NCT00654121
|
